Joseph Ciaffoni
CIK 1443841 · Chief Executive Officer · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$43.17M
Companies
4
Total Filings
61
Lifetime Open-Market Net
-$16.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDV | Chief Executive Officer | 790,330 | $38.70 | $30.59M | $0 | 2 | 2026-06-23 |
| COLL | President and CEO | 444,867 | $27.03 | $12.02M | -$14.98M | 33 | 2024-02-14 |
| ESPR | President and CEO | 177,455 | $3.18 | $564.3K | -$1.95M | 10 | 2019-08-13 |
| Endo International plc (ENDP) Delisted | President, U.S. Branded Pharma | 17,452 | $0.29 | $5.1K | $0 | 1 | 2016-08-18 |
Recent Filings · Page 3 of 7
61 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-31 | COLL | Notice (144) | −31,272 | -$681.7K | EDGAR |
| 2023-05-30 | COLL | Notice (144) | −31,271 | -$706.1K | EDGAR |
| 2023-02-14 | COLL | Mixed | +151,337 | -$2.90M | EDGAR |
| 2022-12-27 | COLL | Sell (S) | −2,461 | -$58.3K | EDGAR |
| 2022-12-21 | COLL | Sell (S) | −17,842 | -$411.8K | EDGAR |
| 2022-12-05 | COLL | Mixed | −54,400 | -$1.76M | EDGAR |
| 2022-11-30 | COLL | Mixed | — | -$262 | EDGAR |
| 2022-11-25 | COLL | Mixed | — | -$396 | EDGAR |
| 2022-11-22 | COLL | Mixed | — | -$12.2K | EDGAR |
| 2022-07-06 | COLL | Tax (F) | −1,394 | -$25.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.